Centiva Capital’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,747
Closed -$253K 1847
2025
Q4
$253K Buy
+2,747
New +$263K ﹤0.01% 911
2025
Q3
Sell
-19,554
Closed -$2.54M 1446
2025
Q2
$2.54M Buy
19,554
+3,938
+25% +$571K 0.04% 278
2025
Q1
$2.49M Buy
15,616
+4,276
+38% +$774K 0.08% 135
2024
Q4
$2.1M Buy
+11,340
New +$2.2M 0.04% 308
2024
Q3
Sell
-9,791
Closed -$1.31M 2370
2024
Q2
$1.31M Buy
9,791
+3,074
+46% +$582K 0.02% 639
2024
Q1
$1.44M Buy
+6,717
New +$1.32M 0.04% 485
2023
Q4
Sell
-9,558
Closed -$1.9M 1997
2023
Q3
$1.9M Sell
9,558
-11,922
-56% -$3.01M 0.04% 403
2023
Q2
$6.97M Buy
+21,480
New +$6.14M 0.15% 118
2020
Q3
Sell
-2,298
Closed -$200K 776
2020
Q2
$200K Buy
+2,298
New +$177K 0.01% 529

Other funds holding INSP

Centiva Capital's INSP Position: Q1 2026 in Review

Centiva Capital sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 2,747 shares — an estimated $253K sold.

Centiva Capital first reported a position in INSP in Q2 2020 and held it in 9 quarters. The position peaked at $6.97M in Q2 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Centiva Capital reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 2,747 Inspire Medical Systems shares in Q1 2026, an estimated $253K.
  • Centiva Capital first reported a position in Inspire Medical Systems in Q2 2020 and held it in 9 quarters.
  • Centiva Capital's Inspire Medical Systems position peaked at $6.97M in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.